Cargando…

Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury

AIMS: MicroRNA (miR)-92a is an important regulator of endothelial proliferation and angiogenesis after ischaemia, but the effects of miR-92a on re-endothelialization and neointimal lesion formation after vascular injury remain elusive. We tested the effects of lowering miR-92a levels using specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniel, Jan-Marcus, Penzkofer, Daniela, Teske, Rebecca, Dutzmann, Jochen, Koch, Alexander, Bielenberg, Wiebke, Bonauer, Angelika, Boon, Reinier A., Fischer, Ariane, Bauersachs, Johann, van Rooij, Eva, Dimmeler, Stefanie, Sedding, Daniel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145012/ https://www.ncbi.nlm.nih.gov/pubmed/25020912 http://dx.doi.org/10.1093/cvr/cvu162

Ejemplares similares

Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation
por: Daniel, Jan-Marcus, et al.
Publicado: (2012)

Phenotypic Characterization of miR-92a(−/−) Mice Reveals an Important Function of miR-92a in Skeletal Development
por: Penzkofer, Daniela, et al.
Publicado: (2014)

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
por: Dutzmann, Jochen, et al.
Publicado: (2017)

Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration
por: Dutzmann, Jochen, et al.
Publicado: (2022)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease
por: Sedding, Daniel G., et al.
Publicado: (2018)

Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice
por: Napp, L. Christian, et al.
Publicado: (2016)

Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’
por: Napp, L. Christian, et al.
Publicado: (2016)

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements
por: Vogt, Alexander, et al.
Publicado: (2023)

The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation
por: Sedding, Daniel, et al.
Publicado: (2006)

Effect of intermittent fasting after ST-elevation myocardial infarction on left ventricular function: study protocol of a pilot randomised controlled trial (INTERFAST-MI)
por: Dutzmann, Jochen, et al.
Publicado: (2022)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

The hydrogen-peroxide producing NADPH oxidase 4 does not limit neointima development after vascular injury in mice
por: Buchmann, Giulia K., et al.
Publicado: (2021)

Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice
por: Stieger, Philipp, et al.
Publicado: (2017)

Clinical ethics case consultation in a university department of cardiology and intensive care: a descriptive evaluation of consultation protocols
por: Nowak, Andre, et al.
Publicado: (2021)

Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET/CT
por: Derlin, Thorsten, et al.
Publicado: (2018)

Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling
por: Hofmann, Patrick, et al.
Publicado: (2019)

Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice
por: Lucas, Tina, et al.
Publicado: (2017)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Uremia does not affect neointima formation in mice
por: Aarup, Annemarie, et al.
Publicado: (2017)

LncRNA AERRIE Is Required for Sulfatase 1 Expression, but Not for Endothelial-to-Mesenchymal Transition
por: Pham, Tan Phát, et al.
Publicado: (2021)

Neointima development in externally stented saphenous vein grafts
por: Węglarz, Przemysław, et al.
Publicado: (2016)

Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation
por: Zhang, Chunxiang, et al.
Publicado: (2004)

A proteomics analysis of neointima formation on decellularized vascular grafts reveals regenerative alterations in protein signature running head: Proteomics analysis of neointima formation
por: Chen, Chunyang, et al.
Publicado: (2022)

Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury
por: Sonnenschein, Kristina, et al.
Publicado: (2019)

Suppression of neointima formation by targeting β-catenin/TCF pathway
por: Williams, Helen, et al.
Publicado: (2016)

Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas
por: Shih, Yu-Chung, et al.
Publicado: (2020)

Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells
por: Stojanović, Stevan D., et al.
Publicado: (2020)

Rosuvastatin reduces neointima formation in a rat model of balloon injury
por: Preusch, MR, et al.
Publicado: (2010)

Antiphospholipid Antibodies Attenuate Endothelial Repair and Promote Neointima Formation in Mice
por: Ulrich, Victoria, et al.
Publicado: (2014)

miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation
por: McDonald, Robert A., et al.
Publicado: (2013)

The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation
por: Fu, Hang, et al.
Publicado: (2019)

The Small Fibrinopeptide Bβ(15–42) as Renoprotective Agent Preserving the Endothelial and Vascular Integrity in Early Ischemia Reperfusion Injury in the Mouse Kidney
por: Urbschat, Anja, et al.
Publicado: (2014)

Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19
por: Schultheiß, Christoph, et al.
Publicado: (2022)

Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo
por: Liu, Rongxia, et al.
Publicado: (2017)

Contribution of Recipient-Derived Cells in Allograft Neointima Formation and the Response to Stent Implantation
por: Ma, Xiaoli, et al.
Publicado: (2008)

Bilirubin Inhibits Neointima Formation and Vascular Smooth Muscle Cell Proliferation and Migration
por: Peyton, Kelly J., et al.
Publicado: (2012)

Interferon regulatory factor 9 is critical for neointima formation following vascular injury
por: Zhang, Shu-Min, et al.
Publicado: (2014)

Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury
por: Ishimura, Shutaro, et al.
Publicado: (2014)

Data on the involvement of Meox1 in balloon-injury-induced neointima formation of rats
por: Wu, Bing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vit6sj6qga6fmu8i0b0bm68mq5